ArticleiScience2026
Realistic PET image synthesis from MRI for automated inference of brain atrophy and Alzheimer's.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neuropathologically validated MRI to tau PET synthesis via Covariate-modulated attention networks.bioRxiv : the preprint server for biology · 2025Article
- Generation of synthetic TSPO PET maps from structural MRI images.Frontiers in neuroinformatics · 2025Article
Corrections and comments
- Update of
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Positron emission tomography (PET) is a crucial tool in medical imaging diagnostics but remains costly and less accessible than alternatives like X-ray and MRI. To address this, we propose MRI2PET, a 3D diffusion-based model that generates AV45-PET scans from T1-weighted MRI images. MRI2PET incorporates style-transferred pre-training and a Laplacian pyramid loss to leverage unpaired MRI data and structural correspondences between modalities while simultaneously emphasizing crucial details. Using the ADNI dataset, we demonstrate MRI2PET produces realistic PET images and improves downstream clinical classification. Notably, augmenting PET-only training data with MRI2PET-synthesized scans increases AUROC from 0.688 ± 0.014 to 0.780 ± 0.005 when classifying into one of cognitively normal, mild cognitive impairment, and Alzheimer's disease groups. These results highlight MRI2PET's ability to generate high quality, clinically informative PET scans from widely available MRI, offering an accessible, cost-effective approach to enhance machine learning performance and expand diagnostic imaging workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.